Medicine
Brimonidine and Timolol 2 mg/5 mg per mL eye drops
Brimonidine and Timolol 2 mg/5 mg per mL eye drops is a generic prescription medicine for ophthalmic use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 15° to 25°C (59° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Brimonidine and Timolol
- Brand
- Sold under the generic name
- Strength
- 2 mg/5 mg per mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle and 24 more
- Manufacturers
- Alembic PharmaceuticalsIndiaGland PharmaIndiaGlenmark PharmaceuticalsIndiaNorthStar RxLLCSandozSomerset TherapeuticsUpsher-Smith LaboratoriesArmas PharmaceuticalsDevatis
- Origin register
- US FDA, United States
- Storage
- Store at 15° to 25°C (59° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 April 2022
- Identifiers
- RxCUI 861635DailyMed set ID af21d2e5-0029-4889-ba93-6417baa91ce6, b5d560b6-847e-4f09-b1ef-22e4deb8a206, e4fdbd17-73b7-49ed-9de3-591f36e0645d +7NDC 0781-7186, 46708-706, 70069-651 +11Application ANDA091087, ANDA215230, ANDA216114 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 68083-624-01 | Gland PharmaIndia | 11 June 2026 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 68083-625-01 | Gland PharmaIndia | 11 June 2026 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 68083-664-01 | Gland PharmaIndia | 11 June 2026 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 46708-706-05 | Alembic PharmaceuticalsIndia | 25 August 2023 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 46708-706-10 | Alembic PharmaceuticalsIndia | 25 August 2023 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 46708-706-15 | Alembic PharmaceuticalsIndia | 25 August 2023 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 62332-706-05 | Alembic PharmaceuticalsIndia | 25 August 2023 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 62332-706-10 | Alembic PharmaceuticalsIndia | 25 August 2023 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 62332-706-15 | Alembic PharmaceuticalsIndia | 25 August 2023 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 68462-281-32 | Glenmark PharmaceuticalsIndia | 16 May 2024 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 68462-281-69 | Glenmark PharmaceuticalsIndia | 16 May 2024 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 70069-651-01 | Somerset Therapeutics | 10 October 2024 |
| 1 bottle in 1 carton / 10 mL in 1 bottle | 70069-652-01 | Somerset Therapeutics | 10 October 2024 |
| 1 bottle in 1 carton / 15 mL in 1 bottle | 70069-653-01 | Somerset Therapeutics | 10 October 2024 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 72485-634-05 | Armas Pharmaceuticals | 3 November 2023 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 72485-634-10 | Armas Pharmaceuticals | 3 November 2023 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 73043-029-01 | Devatis | 15 September 2026 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 73043-029-02 | Devatis | 15 September 2026 |
| 1 bottle in 1 carton / 10 mL in 1 bottle | 0781-7186-70 | Sandoz | 13 April 2022 |
| 1 bottle in 1 carton / 5 mL in 1 bottle | 0781-7186-75 | Sandoz | 13 April 2022 |
| 1 bottle in 1 carton / 15 mL in 1 bottle | 0781-7186-85 | Sandoz | 13 April 2022 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 0832-1425-05 | Upsher-Smith Laboratories | 9 January 2023 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 0832-1425-10 | Upsher-Smith Laboratories | 9 January 2023 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 0832-1425-15 | Upsher-Smith Laboratories | 20 October 2023 |
| 1 bottle, dropper in 1 carton / 5 mL in 1 bottle, dropper | 72603-931-05 | NorthStar RxLLC | 24 April 2026 |
| 1 bottle, dropper in 1 carton / 10 mL in 1 bottle, dropper | 72603-931-10 | NorthStar RxLLC | 24 April 2026 |
| 1 bottle, dropper in 1 carton / 15 mL in 1 bottle, dropper | 72603-931-15 | NorthStar RxLLC | 28 September 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 October 2007 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Brimonidine and Timolol 2 mg/5 mg per mL eye drops.
Other strengths and forms of Brimonidine and Timolol
Clinical summary
Brimonidine and Timolol is a fixed-dose combination of an alpha-adrenergic agonist and a beta-adrenergic blocker indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension, among other approved uses. MedsAcross supplies Brimonidine and Timolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Brimonidine and TimololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- COMBIGAN prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Brimonidine and Timolol 2 mg/5 mg per mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.